glp 1 agonist exenatide America's Poison Centers History of glucagon-like peptide-1 receptor

All reviewers took part in the data extraction

Shah, and K

wrote minor parts of the manuscript

A spokesperson from Eli Lilly also said that hair loss has been observed with weight loss interventions and that the side effect is listed on Zepbound labels but not Mounjaro, as it is an adjunct to diet and exercise to help improve glycemic control in adults with type 2 diabetes

The first GLP-1 drugs developed are self-administered via daily or weekly subcutaneous (under the skin) injections using a pre-filled pen

Because these patches are not standardized or FDA-approved, there are no consistent dosing or wear-time guidelines, which is one reason clinicians recommend caution